(Q48212390)

9 February 2018

title

Serum uric acid in patients with Parkinson's disease and vascular parkinsonism: a cross-sectional study (English)

1 reference

9 February 2018

1 reference

parkinsonian syndrome

1 reference

Mengqiu Pan

1

1 reference

9 February 2018

Huimin Gao

2

1 reference

9 February 2018

Ling Long

3

1 reference

9 February 2018

Yunqi Xu

4

1 reference

9 February 2018

Mei Liu

5

1 reference

9 February 2018

Jing Zou

6

1 reference

9 February 2018

Aimin Wu

7

1 reference

9 February 2018

Xiaobo Wei

8

1 reference

9 February 2018

Xiaohong Chen

9

1 reference

9 February 2018

Beisha Tang

10

1 reference

9 February 2018

Qing Wang

11

1 reference

9 February 2018

publication date

14 November 2012

1 reference

9 February 2018

published in

Neuroimmunomodulation

1 reference

9 February 2018

volume

20

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

19-28

1 reference

9 February 2018

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

cites work

1 reference

Inflammation and Parkinson's disease pathogenesis

21 January 2018

1 reference

Peripheral inflammatory biomarkers and risk of Parkinson's disease

21 January 2018

1 reference

Oxidative damage in Parkinson disease: Measurement using accurate biomarkers.

21 January 2018

1 reference

Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor α in the nigrostriatal dopaminergic circuit of adult mice

21 January 2018

1 reference

Striatal neuroinflammation promotes Parkinsonism in rats

21 January 2018

1 reference

Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson's disease

21 January 2018

1 reference

Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery

21 January 2018

1 reference

Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention

21 January 2018

1 reference

Non-steroidal anti-inflammatory drugs in Parkinson's disease

21 January 2018

1 reference

Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke

21 January 2018

1 reference

Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?

21 January 2018

1 reference

Plasma urate and risk of Parkinson's disease

21 January 2018

1 reference

Urate as a predictor of the rate of clinical decline in Parkinson disease

21 January 2018

1 reference

Plasma urate and Parkinson's disease in women

21 January 2018

1 reference

The combination of homocysteine and C-reactive protein predicts the outcomes of Chinese patients with Parkinson's disease and vascular parkinsonism

21 January 2018

1 reference

Parkinson disease. Nonmotor symptoms in Parkinson disease: the PRIAMO study.

21 January 2018

1 reference

Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis

21 January 2018

1 reference

Impact of pre-morbid depression on health-related quality of life in non-demented Parkinson's disease patients

21 January 2018

1 reference

Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson's disease

21 January 2018

1 reference

Vascular parkinsonism: a clinical review

21 January 2018

1 reference

The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study

21 January 2018

1 reference

21 January 2018

1 reference

A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials

21 January 2018

1 reference

Etiology and pathogenesis of Parkinson's disease

21 January 2018

1 reference

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

Altered uric acid levels and disease states

21 January 2018

1 reference

Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarization.

21 January 2018

1 reference

Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease

21 January 2018

1 reference

Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.

21 January 2018

1 reference

Uric acid is reduced in the substantia nigra in Parkinson's disease: effect on dopamine oxidation

21 January 2018

1 reference

Uric acid and cognition in Parkinson's disease: a follow-up study.

21 January 2018

1 reference

Serum uric acid and cognitive function and dementia

21 January 2018

1 reference

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease

21 January 2018

1 reference

Mitochondria as therapeutic targets of estrogen action in the central nervous system

21 January 2018

1 reference

Uric acid in Parkinson's disease

21 January 2018

1 reference

The relationship between uric acid levels and Huntington's disease progression

21 January 2018

1 reference

Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

21 January 2018

1 reference

Serum uric acid levels and the risk of Parkinson disease

21 January 2018

1 reference

Antioxidant Profile and Early Outcome in Stroke Patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000342483

1 reference

9 February 2018

release_skuq4l5fsjfrzadxxniztrkk6u

Fatcat ID

0 references

1 reference

9 February 2018